ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Exscientia plc (EXAI) stock remained unchanged at -, trading at $4.84 on NASDAQ, unchanged from the previous close of -. The stock opened at -, fluctuating between $4.84 and $4.84 in the recent session.
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Employees | 483 |
Beta | 0.83 |
Sales or Revenue | $24.96M |
5Y Sales Change% | 0.63% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |